Information de reference pour ce titreAccession Number: | 00009733-201902000-00016.
|
Author: | Wang, Juan MD, PhD 1; Yang, Yan-min MD, PhD *,1; Li, Yang PhD *,2; Zhu, Jun MD, PhD 1; Lian, Hong PhD 3; Shao, Xing-hui MD, PhD 1; Zhang, Han MD, PhD 1; Fu, Yi-cheng MD, PhD 4; Zhang, Lian-feng PhD 5
|
Institution: | (1) Emergency and Intensive Care Center, State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College Beijing China (2) Department of Cardiology Chinese PLA General Hospital Beijing China (3) State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China (4) Department of Geriatrics Peking University Third Hospital Beijing China (5) Key Laboratory of Human Disease Comparative Medicine Ministry of Health, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
|
Title: | |
Source: | Journal of Cardiovascular Electrophysiology. 30(2):242-252, February 2019.
|
Author Keywords: | atrial fibrillation; funny current; hyperpolarization-activated cyclic nucleotide gated channels; Ivabradine; transgenic mice.
|
References: | 1. Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. 2016
2. Nattel S, Dobrev D. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol. 2016;13(10):575-590.
3. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res. 2010;106(3):434-446.
4. Wahl-Schott C, Fenske S, Biel M. HCN channels: new roles in sinoatrial node function. Curr Opin Pharmacol. 2014;15C:83-90.
5. Roubille F, Tardif JC. New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels. Circulation. 2013;127(19):1986-1996.
6. Heusch G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Brit J Pharmacol. 2008;153(8):1589-1601.
7. Kuwabara Y, Kuwahara K, Takano M, et al. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J Am Heart Assoc. 2013;2(3):e150.
8. Suffredini S, Stillitano F, Comini L, et al. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol. 2012;165(5):1457-1466.
9. Lian H, Wang X, Wang J, et al. Heart-specific overexpression of (pro)renin receptor induces atrial fibrillation in mice. Int J Cardiol. 2015;184C:28-35.
10. Yasui K, Liu W, Opthof T, et al. I(f) current and spontaneous activity in mouse embryonic ventricular myocytes. Circ Res. 2001;88(5):536-542.
11. Stillitano F, Sartiani L, DePaoli P, Mugelli A, Cerbai E. Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factors. Pharmacol Res. 2008;57(2):100-109.
12. Michels G, Er F, Khan I, Sudkamp M, Herzig S, Hoppe UC. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation. 2005;111(4):399-404.
13. Stillitano F, Lonardo G, Giunti G, et al. Chronic atrial fibrillation alters the functional properties of If in the human atrium. J Cardiovasc Electrophysiol. 2013;24(12):1391-1400.
14. Lai LP, Su MJ, Lin JL, et al. Measurement of funny current (I(f)) channel mRNA in human atrial tissue: correlation with left atrial filling pressure and atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10(7):947-953.
15. Zicha S, Fernandez-Velasco M, Lonardo G, L'Heureux N, Nattel S. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc Res. 2005;66(3):472-481.
16. Suenari K, Cheng CC, Chen YC, et al. Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol. 2012;23(2):200-206.
17. Kroller-Schon S, Schulz E, Wenzel P, et al. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res Cardiol. 2011;106(6):1147-1158.
18. Ng FS, Shadi IT, Peters NS, Lyon AR. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias. J Mol Cell Cardiol. 2013;59:67-75.
19. Martin RI, Pogoryelova O, Koref MS, Bourke JP, Teare MD, Keavney BD. Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials. Heart. 2014;100(19):1506-1510.
20. Fox K, Ford I, Steg PG, et al. Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. Eur Heart J. 2015;36(46):3291-3296.
|
Language: | English.
|
Document Type: | ORIGINAL ARTICLES.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 1045-3873
|
NLM Journal Code: | by4, 9010756
|
DOI Number: | https://dx.doi.org/10.1111/jce.1...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|